Key Points
- Grigorios Siokas purchased 76,360 shares of Cosmos Health on Nov. 28 at $0.64 each, raising his stake to 6,459,985 shares (a 1.20% increase) valued at about $4.13 million, per an SEC filing.
- Siokas made multiple insider buys across November totaling 301,101 shares for roughly $194,000, indicating significant insider accumulation during the month.
- Cosmos Health is a small-cap (~$19.65M) with a recent quarterly EPS of -$0.17 (missing estimates), negative margins and ROE, and a consensus analyst rating of Sell, although Citadel recently increased its institutional stake to about 0.65% and institutions own ~12.6% overall.
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 76,360 shares of the stock in a transaction dated Friday, November 28th. The stock was bought at an average cost of $0.64 per share, with a total value of $48,870.40. Following the completion of the purchase, the chief executive officer owned 6,459,985 shares in the company, valued at $4,134,390.40. The trade was a 1.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Tuesday, November 25th, Grigorios Siokas acquired 55,732 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.63 per share, for a total transaction of $35,111.16.
- On Friday, November 21st, Grigorios Siokas bought 56,080 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.68 per share, with a total value of $38,134.40.
- On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The stock was purchased at an average price of $0.62 per share, for a total transaction of $31,815.30.
- On Wednesday, November 19th, Grigorios Siokas purchased 61,614 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.65 per share, with a total value of $40,049.10.
Cosmos Health Price Performance
COSM opened at $0.56 on Tuesday. The stock has a market cap of $19.65 million, a P/E ratio of -0.75 and a beta of 5.34. Cosmos Health Inc. has a 12 month low of $0.28 and a 12 month high of $1.32. The company has a quick ratio of 0.84, a current ratio of 0.99 and a debt-to-equity ratio of 0.25. The company has a fifty day simple moving average of $0.89 and a 200 day simple moving average of $0.72.
Cosmos Health (NASDAQ:COSM - Get Free Report) last posted its earnings results on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%.The business had revenue of $17.11 million for the quarter, compared to the consensus estimate of $16.40 million. On average, research analysts expect that Cosmos Health Inc. will post -0.78 EPS for the current year.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on COSM. Wall Street Zen upgraded Cosmos Health to a "hold" rating in a research report on Saturday, September 20th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Cosmos Health in a report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Cosmos Health presently has a consensus rating of "Sell".
Get Our Latest Report on COSM
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC boosted its position in Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 133.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 225,507 shares of the company's stock after buying an additional 128,776 shares during the quarter. Citadel Advisors LLC owned approximately 0.65% of Cosmos Health worth $250,000 as of its most recent filing with the SEC. 12.61% of the stock is currently owned by institutional investors and hedge funds.
About Cosmos Health
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
